SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc.
(NASDAQ: BIOC), a leading commercial provider of liquid biopsy
tests designed to provide physicians with clinically actionable
information to improve the outcomes of cancer patients, announces
that it will release financial results for the fourth quarter and
full year ended December 31, 2016
after the market closes on Tuesday, March 7,
2017. Biocept management will hold a conference call
for the investment community to discuss the results and answer
questions at 4:30 p.m. Eastern time
(1:30 p.m. Pacific time).
Individuals interested in participating on the conference call
may do so by dialing (855) 656-0927 for domestic callers, (855)
669-9657 for Canadian callers, or (412) 902-4109 for other
international callers. Those interested in listening to a webcast
of the live conference call may do so by visiting
https://www.webcaster4.com/Webcast/Page/1271/19739.
A replay of the conference call will be available for 48 hours
following the conclusion of the call by dialing (877) 344-7529 for
domestic callers, (855) 669-9658 for Canadian callers, or (412)
317-0088 for other international callers, and entering the replay
access code 10101325. A webcast replay will be available for
90 days at http://ir.biocept.com/events.cfm.
About Biocept
Biocept, Inc. is a molecular diagnostics company with
commercialized assays for lung, breast, gastric, colorectal and
prostate cancers, and melanoma. The Company uses its
proprietary liquid biopsy technology to provide physicians with
clinically actionable information for treating and monitoring
patients diagnosed with cancer. The Company's patented Target
Selector™ liquid biopsy technology platform captures and analyzes
tumor-associated molecular markers in both circulating tumor cells
(CTCs) and in circulating tumor DNA (ctDNA). With thousands
of tests performed, the platform has demonstrated the ability to
identify cancer mutations and alterations to inform physicians
about a patient's disease and therapeutic options. For additional
information, please visit www.biocept.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biocept-to-release-2016-fourth-quarter-and-full-year-financial-results-and-host-investor-conference-call-on-march-7-2017-300409693.html
SOURCE Biocept, Inc.